Showing 1 - 7 results of 7 for search 'Che-Ming Teng', query time: 0.11s Refine Results
  1. 1
    The Inhibitory Mechanism of YC-1, a Benzyl Indazole, on Smooth Muscle Cell Proliferation: an In Vitro and In Vivo Study

    The Inhibitory Mechanism of YC-1, a Benzyl Indazole, on Smooth Muscle Cell Proliferation: an In Vitro and In Vivo Study by Chieh-Hsi Wu, Weng-Cheng Chang, Gee-Yat Chang, Sheng-Chu Kuo, Che-Ming Teng

    Published 2004-01-01
    Get full text
    Article
  2. 2
    α-Tomatine-mediated anti-cancer activity in vitro and in vivo through cell cycle- and caspase-independent pathways.

    α-Tomatine-mediated anti-cancer activity in vitro and in vivo through cell cycle- and caspase-independent pathways. by Min-Wu Chao, Chun-Han Chen, Ya-Ling Chang, Che-Ming Teng, Shiow-Lin Pan

    Published 2012-01-01
    Get full text
    Article
  3. 3
    MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.

    MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27. by Hui Chen Pai, Sunil Kumar, Chien-Chang Shen, Jing Ping Liou, Shiow Lin Pan, Che Ming Teng

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Aciculatin inhibits granulocyte colony-stimulating factor production by human interleukin 1β-stimulated fibroblast-like synoviocytes.

    Aciculatin inhibits granulocyte colony-stimulating factor production by human interleukin 1β-stimulated fibroblast-like synoviocytes. by Kao-Shang Shih, Jyh-Horng Wang, Yi-Wen Wu, Che-Ming Teng, Chien-Chih Chen, Chia-Ron Yang

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways.

    Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways. by Chih-Ya Wang, An-Chi Tsai, Chieh-Yu Peng, Ya-Ling Chang, Kuo-Hsiung Lee, Che-Ming Teng, Shiow-Lin Pan

    Published 2012-01-01
    Get full text
    Article
  6. 6
    Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo.

    Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo. by Han-Li Huang, Hsueh-Yun Lee, An-Chi Tsai, Chieh-Yu Peng, Mei-Jung Lai, Jing-Chi Wang, Shiow-Lin Pan, Che-Ming Teng, Jing-Ping Liou

    Published 2012-01-01
    Get full text
    Article
  7. 7
    Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

    Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status by Min-Wu Chao, Li-Hsun Chang, Huang-Ju Tu, Chao-Di Chang, Mei-Jung Lai, Yi-Ying Chen, Jing-Ping Liou, Che-Ming Teng, Shiow-Lin Pan

    Published 2019-05-01
    Get full text
    Article

Search Tools: